Spots Global Cancer Trial Database for recurrent childhood large cell lymphoma
Every month we try and update this database with for recurrent childhood large cell lymphoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma | NCT00006102 | Brain and Centr... Lymphoma Neuroblastoma Retinoblastoma Sarcoma Unspecified Chi... | becatecarin | - 21 Years | National Cancer Institute (NCI) | |
| Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy | NCT00891137 | Leukemia Lymphoma Multiple Myelom... Plasma Cell Neo... Myelodysplastic... | human myeloid p... | 12 Years - 65 Years | Cellerant Therapeutics | |
| Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer | NCT00003661 | Graft Versus Ho... Leukemia Lymphoma Myelodysplastic... Neuroblastoma | anti-thymocyte ... busulfan cyclosporine melphalan methylprednisol... umbilical cord ... radiation thera... | - 54 Years | Roswell Park Cancer Institute | |
| Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia, Osteosarcoma, or Non-Hodgkin's Lymphoma | NCT00002738 | Leukemia Lymphoma Sarcoma | leucovorin calc... trimetrexate gl... | - 21 Years | Memorial Sloan Kettering Cancer Center | |
| Ex Vivo Drug Sensitivity Testing and Mutation Profiling | NCT03860376 | Recurrent Child... Recurrent Child... Recurrent Child... Refractory Chil... Refractory Chil... Refractory Chil... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Refractory Chro... | 1 Day - 21 Years | Florida International University | ||
| Combination Chemotherapy in Treating Patients With Acute B-Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma | NCT00002471 | Leukemia Lymphoma | asparaginase cyclophosphamid... cytarabine daunorubicin hy... dexamethasone etoposide leucovorin calc... methotrexate methylprednisol... therapeutic hyd... thiotepa vincristine sul... | - | Memorial Sloan Kettering Cancer Center | |
| Chemotherapy and Total-Body Irradiation Followed by Donor Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic Cancer | NCT00290641 | Chronic Myelopr... Leukemia Lymphoma Myelodysplastic... | filgrastim graft-versus-tu... cyclophosphamid... cyclosporine fludarabine pho... mycophenolate m... umbilical cord ... radiation thera... | - 45 Years | Masonic Cancer Center, University of Minnesota | |
| Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer | NCT00003661 | Graft Versus Ho... Leukemia Lymphoma Myelodysplastic... Neuroblastoma | anti-thymocyte ... busulfan cyclosporine melphalan methylprednisol... umbilical cord ... radiation thera... | - 54 Years | Roswell Park Cancer Institute | |
| Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia, Osteosarcoma, or Non-Hodgkin's Lymphoma | NCT00002738 | Leukemia Lymphoma Sarcoma | leucovorin calc... trimetrexate gl... | - 21 Years | Memorial Sloan Kettering Cancer Center | |
| Gallium Nitrate in Treating Children With Brain Tumor, Neuroblastoma, Rhabdomyosarcoma, Non-Hodgkin's Lymphoma, or Refractory Solid Tumors | NCT00002543 | Brain and Centr... Lymphoma Neuroblastoma Sarcoma Unspecified Chi... | gallium nitrate | - 21 Years | National Cancer Institute (NCI) | |
| BL22 Immunotoxin In Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma | NCT00077493 | Leukemia Lymphoma | BL22 immunotoxi... antibody-drug c... immunotoxin the... monoclonal anti... | 6 Months - 24 Years | MedImmune LLC | |
| Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma | NCT00363272 | Childhood Burki... Childhood Centr... Childhood Choro... Childhood Crani... Childhood Grade... Childhood Grade... Childhood Grade... Childhood High-... Childhood Infra... Childhood Low-g... Childhood Spina... Childhood Supra... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Unspecified Chi... | ispinesib laboratory biom... pharmacological... | 1 Year - 21 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy and Rituximab in Treating Young Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia | NCT00058461 | B-cell Childhoo... Childhood Burki... Childhood Diffu... Childhood Immun... L3 Childhood Ac... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... | ifosfamide etoposide rituximab carboplatin filgrastim methotrexate cytarabine laboratory biom... | - 21 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia, Osteosarcoma, or Non-Hodgkin's Lymphoma | NCT00002738 | Leukemia Lymphoma Sarcoma | leucovorin calc... trimetrexate gl... | - 21 Years | Memorial Sloan Kettering Cancer Center | |
| Combination Chemotherapy and Rituximab in Treating Young Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia | NCT00058461 | B-cell Childhoo... Childhood Burki... Childhood Diffu... Childhood Immun... L3 Childhood Ac... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... | ifosfamide etoposide rituximab carboplatin filgrastim methotrexate cytarabine laboratory biom... | - 21 Years | National Cancer Institute (NCI) | |
| Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy | NCT00891137 | Leukemia Lymphoma Multiple Myelom... Plasma Cell Neo... Myelodysplastic... | human myeloid p... | 12 Years - 65 Years | Cellerant Therapeutics | |
| Gallium Nitrate in Treating Children With Brain Tumor, Neuroblastoma, Rhabdomyosarcoma, Non-Hodgkin's Lymphoma, or Refractory Solid Tumors | NCT00002543 | Brain and Centr... Lymphoma Neuroblastoma Sarcoma Unspecified Chi... | gallium nitrate | - 21 Years | National Cancer Institute (NCI) | |
| Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases | NCT00309842 | Acute Myeloid L... Acute Lymphocyt... Chronic Myeloge... Myelofibrosis MDS Refractory Anem... Chronic Lymphoc... Prolymphocytic ... Non-Hodgkin's L... Leukemia Lymphoma Multiple Myelom... Myelodysplastic... | filgrastim cyclophosphamid... cyclosporine fludarabine pho... mycophenolate m... umbilical cord ... total-body irra... | - 55 Years | Masonic Cancer Center, University of Minnesota | |
| Monoclonal Antibody Therapy in Treating Patients With Recurrent Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma | NCT00004858 | Leukemia Lymphoma | B43-genistein i... | - 80 Years | National Cancer Institute (NCI) | |
| Radiation Therapy and Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With High-Grade Lymphoma or Acute Lymphoblastic Leukemia | NCT00004898 | Leukemia Lymphoma | filgrastim cyclophosphamid... etoposide peripheral bloo... radiation thera... | - 65 Years | Northwestern University | |
| Bone Marrow Transplantation in Treating Patients With Hematologic Cancer | NCT00005854 | Leukemia Lymphoma Multiple Myelom... Myelodysplastic... | cyclophosphamid... cyclosporine methotrexate allogeneic bone... in vitro-treate... radiation thera... | - 50 Years | Fred Hutchinson Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
